INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy Study

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The central hypothesis is that inflammation mediators are biomarkers of both systemic diabetes and Diabetic Retinopathy (DR) progression in the aqueous and that sustained topical ketorolac application reduces/suppresses those inflammatory mediators thereby reducing the progression of Diabetic Retinopathy.
Epistemonikos ID: c351106fa753eff6b0c79566e5b5e600ff2640e9
First added on: May 07, 2024